Trial Details
UNKNOWNBasic Information
| Clinical ID | c3050 |
|---|---|
| Identifier | NCT02597829 |
| Trial Title | Does Clinical Response Correlate With Serum Certolizumab Levels? |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Certolizumab Pegol |
Participant Information
| Sponsor | Shafran Gastroenterology Center |
|---|---|
| City | Winter Park |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2015-11 |
|---|---|
| Primary Completion Date | 2018-05 |
| Completion Date | 2018-10 |